Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isaac Crespo

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Nature Immunology|April 20, 2023
Orthogonal cytokine engineering enables novel synthetic effector states escaping canonical exhaustion in tumor-rejecting CD8<sup>+</sup> T cellsJesus Corria-Osorio, Santiago J Carmona, Evangelos Stefanidis, et al.
The Journal of Experimental Medicine|June 22, 2026
The transcription factor IRF8 drives tumor-specific exhaustion in CD8+ T cellsMarco Ongaro, Romane Thouenon, Isaac Crespo, et al.
Molecular Neurobiology|July 9, 2013
Integrating pathways of Parkinson's disease in a molecular interaction mapKazuhiro A Fujita, Marek Ostaszewski, Yukiko Matsuoka, et al.
Plos Computational Biology|March 14, 2015
Angiogenic activity of breast cancer patients' monocytes reverted by combined use of systems modeling and experimental approachesNicolas Guex, Isaac Crespo, Sylvian Bron, et al.
Genome Medicine|November 2, 2016
Identification of a RAI1-associated disease network through integration of exome sequencing, transcriptomics, and 3D genomicsMaria Nicla Loviglio, Christine R Beck, Janson J White, et al.
Immunity|September 14, 2024
Tumor-reactive T cell clonotype dynamics underlying clinical response to TIL therapy in melanomaJohanna Chiffelle, David Barras, Rémy Pétremand, et al.
Cancer Discovery|September 4, 2021
Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to ImmunotherapyFernanda G Herrera, Catherine Ronet, Maria Ochoa de Olza, et al.
Cancer Cell|November 5, 2021
Myeloid antigen-presenting cell niches sustain antitumor T cells and license PD-1 blockade via CD28 costimulationJaikumar Duraiswamy, Riccardo Turrini, Aspram Minasyan, et al.
Nature|April 24, 2024
PGE<sub>2</sub> inhibits TIL expansion by disrupting IL-2 signalling and mitochondrial functionMatteo Morotti, Alizee J Grimm, Helen Carrasco Hope, et al.
Science Immunology|February 2, 2024
Response to tumor-infiltrating lymphocyte adoptive therapy is associated with preexisting CD8<sup>+</sup> T-myeloid cell networks in melanomaDavid Barras, Eleonora Ghisoni, Johanna Chiffelle, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Nature Immunology|April 20, 2023
Orthogonal cytokine engineering enables novel synthetic effector states escaping canonical exhaustion in tumor-rejecting CD8<sup>+</sup> T cellsJesus Corria-Osorio, Santiago J Carmona, Evangelos Stefanidis, et al.
The Journal of Experimental Medicine|June 22, 2026
The transcription factor IRF8 drives tumor-specific exhaustion in CD8+ T cellsMarco Ongaro, Romane Thouenon, Isaac Crespo, et al.
Molecular Neurobiology|July 9, 2013
Integrating pathways of Parkinson's disease in a molecular interaction mapKazuhiro A Fujita, Marek Ostaszewski, Yukiko Matsuoka, et al.
Plos Computational Biology|March 14, 2015
Angiogenic activity of breast cancer patients' monocytes reverted by combined use of systems modeling and experimental approachesNicolas Guex, Isaac Crespo, Sylvian Bron, et al.
Genome Medicine|November 2, 2016
Identification of a RAI1-associated disease network through integration of exome sequencing, transcriptomics, and 3D genomicsMaria Nicla Loviglio, Christine R Beck, Janson J White, et al.
Immunity|September 14, 2024
Tumor-reactive T cell clonotype dynamics underlying clinical response to TIL therapy in melanomaJohanna Chiffelle, David Barras, Rémy Pétremand, et al.
Cancer Discovery|September 4, 2021
Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to ImmunotherapyFernanda G Herrera, Catherine Ronet, Maria Ochoa de Olza, et al.
Cancer Cell|November 5, 2021
Myeloid antigen-presenting cell niches sustain antitumor T cells and license PD-1 blockade via CD28 costimulationJaikumar Duraiswamy, Riccardo Turrini, Aspram Minasyan, et al.
Nature|April 24, 2024
PGE<sub>2</sub> inhibits TIL expansion by disrupting IL-2 signalling and mitochondrial functionMatteo Morotti, Alizee J Grimm, Helen Carrasco Hope, et al.
Science Immunology|February 2, 2024
Response to tumor-infiltrating lymphocyte adoptive therapy is associated with preexisting CD8<sup>+</sup> T-myeloid cell networks in melanomaDavid Barras, Eleonora Ghisoni, Johanna Chiffelle, et al.
Pageof 3